The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand's disease and hemophilia
✍ Scribed by Köhler, M. ;Hellstern, P. ;Reiter, B. ;Blohn, G. ;Wenzel, E.
- Publisher
- Springer-Verlag
- Year
- 1984
- Tongue
- English
- Weight
- 703 KB
- Volume
- 62
- Category
- Article
- ISSN
- 1432-1440
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A 19‐year‐old male patient with type 1 von Willebrand's disease underwent two separate superficial inferior epigastric artery free flap tissue transfers and three revision procedures for reconstruction of a postextirpative mid‐facial defect. Intravenous 1‐desamino‐8‐D‐arginine vasopress
DDAVP is effective treatment in most types of von Willebrand's disease; however, in type 28 von Willebrand's disease the use of DDAVP has been contraindicated due to DDAVPinduced thrombocytopenla. Several reports have confirmed the thrombocytopenic effects of DDAVP and the presence of circulating pl